CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-15 | Grant Sean Chief Financial Officer | Purchase | +857 | $13.60 | $12K | 857 |
| 2022-06-15 | Grant Sean Chief Financial Officer | Purchase | +992 | $13.60 | $13K | 992 |
| 2022-05-31 | Curley Joanne Chief Development Officer | Option exercise | +400 | $6.37 | $3K | 25,594 |
| 2022-05-31 | Curley Joanne Chief Development Officer | Sale | −400 | $15.22 | $6K | 25,194 |
| 2022-05-31 | Curley Joanne Chief Development Officer | Option exercise · Stock Option (right to buy) | −400 | 25,491 | ||
| 2022-05-24 | Hall Kimball Director | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 | ||
| 2022-05-24 | Cheng Andrew Director | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 | ||
| 2022-05-24 | ENRIGHT PATRICK G Director | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 | ||
| 2022-05-24 | Katabi Maha Director | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 | ||
| 2022-05-24 | Morrison Scott W Director | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 | ||
| 2022-05-24 | SEIDENBERG BETH C Director | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 | ||
| 2022-05-24 | MORRISSEY MICHAEL Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-02-16 | Curley Joanne Chief Development Officer | Grant or award · Stock Option (right to buy) | +52,964 | 52,964 | ||
| 2022-02-16 | Lin Celia Chief Medical Officer | Grant or award · Stock Option (right to buy) | +52,412 | 52,412 | ||
| 2022-02-16 | Young Joseph R SVP, Finance, Chief Acct Offcr | Grant or award · Stock Option (right to buy) | +36,729 | 36,729 | ||
| 2022-02-16 | Grant Sean Chief Financial Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2022-02-16 | Fordyce Marshall President and CEO | Grant or award · Stock Option (right to buy) | +176,154 | 176,154 | ||
| 2022-02-10 | Longitude Capital Partners IV, LLC 10% owner | Purchase | +333,333 | $15.00 | $5.0M | 3,429,927 |
| 2022-02-10 | ENRIGHT PATRICK G Director | Purchase | +333,333 | $15.00 | $5.0M | 3,429,927 |
| 2022-02-10 | Sofinnova Venture Partners X, L.P. 10% owner | Purchase | +266,666 | $15.00 | $4.0M | 3,181,442 |
Page 27 of 30 · 581 trades